1 |
Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis [J]. Respiration, 2003, 70(1): 7-30.
|
2 |
恽佶例, 李小鹰. 静脉血栓栓塞症的病理流行病学研究状况 [J]. 中华老年心脑血管病杂志, 2017, 19(3): 322-324.
|
3 |
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) [J]. Chest, 2008, 133(6 Suppl): 381S-453S.
|
4 |
Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review [J]. J Clin Pathol, 2004, 57(12): 1254-1257.
|
5 |
Angchaisuksiri P. Venous thromboembolism in Asia--an unrecognised and under-treated problem? [J]. Thromb Haemost, 2011, 106(4): 585-590.
|
6 |
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e227S-e277S.
|
7 |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score [J]. J Thromb Haemost, 2010, 8(11): 2450-2457.
|
8 |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report [J]. Chest, 2016, 149(2): 315-352.
|
9 |
Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method [J]. Ann Surg, 2010, 251(2): 344-350.
|
10 |
Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients [J]. J Am Coll Surg, 2011, 212(1): 105-112.
|
11 |
Stroud W, Whitworth JM, Miklic M, et al. Validation of a venous thromboembolism risk assessment model in gynecologic oncology [J]. Gynecol Oncol, 2014, 134(1): 160-163.
|
12 |
Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score [J]. J Thromb Haemost, 2004, 2(12): 2156-2161.
|
13 |
Pop TR, Vesa SC, Trifa AP, et al. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis [J]. Rom J Morphol Embryol, 2014, 55(1): 153-157.
|
14 |
Nendaz M, Spirk D, Kucher N, et al. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE) [J]. Thromb Haemost, 2014, 111(3): 531-538.
|